about
Fragment-Based Covalent Ligand Screening Enables Rapid Discovery of Inhibitors for the RBR E3 Ubiquitin Ligase HOIPRevisiting Bromohexitols as a Novel Class of Microenvironment-Activated Prodrugs for Cancer TherapySingle-Domain Antibodies as Crystallization Chaperones to Enable Structure-Based Inhibitor Development for RBR E3 Ubiquitin Ligases
P50
description
researcher (ORCID 0000-0002-9990-6261)
@en
name
Henrik Johansson
@en
type
label
Henrik Johansson
@en
prefLabel
Henrik Johansson
@en
P31
P496
0000-0002-9990-6261